Study data from Central Hospital update knowledge of breast cancer therapy

Researchers detail in "Cost-effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40-49 years," new data in breast cancer. "Although the introduction of screening mammography in Japan would be expected to reduce mortality from breast cancer, the optimal screening modality in terms of cost-effectiveness remains unclear. We compared the cost-effectiveness ratio, defined as the cost required for a life-year saved, among the following three strategies: (1) annual clinical breast examination; (2) annual clinical breast examination combined with mammography; and (3) biennial clinical breast examination combined with mammography for women...

Want to see the full article?

• Purchase this article for only $3.00